» News » Sero survey shows 56% of Delhi residents have Covid antibodies

Sero survey shows 56% of Delhi residents have Covid antibodies

Source: PTI   -  Edited By: Utkarsh Mishra
February 02, 2021 17:04 IST
Get Rediff News in your Inbox:

Delhi Health Minister Satyendar Jain said on Tuesday 56.13 per cent of those covered under the latest serological survey in the city in January have developed antibodies against coronavirus.


IMAGE: A healthcare worker fills a syringe with a dose of Bharat Biotech's Covaxin, during vaccination campaign at All India Institute of Medical Sciences (AIIMS) in New Delhi. Photograph: Adnan Abidi/Reuters

The minister also said Delhi was 'moving towards herd immunity, but only experts will be able to give a clear picture'.

The fifth sero survey -- the largest in the country so far -- was conducted from January 15 to January 23, he said.

At 62.18 per cent, Southwest Delhi district reported maximum sero prevalence. North Delhi at 49.09 percent recorded the lowest, Jain said.

"A new, better technology was used during the survey. Samples were collected from every ward. In all, 28,000 samples were taken," a senior official said.

The minister said the number of cases, fatalities and hospital admissions have declined significantly, but insisted that people should continue use masks for a few more months and maintain 'COVID-19-approriate behavior'.

Jain said three major changes were incorporated during the latest survey.

"We increased the sample size. Samples were collected on the basis of socio-economic conditions.

"A new, more sensitive kit was used and the testing was conducted at Institute of Liver and Biliary Sciences," he said.

The minister also informed that frontline workers will start getting COVID-19 vaccine jabs this week.

Nearly six lakh frontline workers, including government school teachers, MCD employees, police personnel, ASHA and ANM workers, are expected to be administered the vaccine.

Get Rediff News in your Inbox:
Source: PTI  -  Edited By: Utkarsh Mishra© Copyright 2021 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
The War Against Coronavirus

The War Against Coronavirus